NEW FOLLOW-UP STUDY SHOWS THAT A NATURALLY OCCURRING COENZYME NUTRITIONAL SUPPLEMENT ENADA® NADH CLINICALLY DEMONSTRATES BENEFITS FOR ALZHEIMER’S PATIENTS To read the study please click this link : Nov 2002 ICMAN Study on Alzheimers 2nd International Conference on Mechanisms and Actions of Nutraceuticals October 6 -9, 2002 Krems/Danube AUSTRIA November 19, 2002 NEW FOLLOW-UP STUDY SHOWS THAT A NATURALLY OCCURRING COENZYME NUTRITIONAL SUPPLEMENT ENADA® NADH CLINICALLY DEMONSTRATES BENEFITS FOR ALZHEIMER’S PATIENTS Vienna, Austria (11/02) – At the 2nd International Conference on Mechanisms and Actions of Nutraceuticals (ICMAN) the findings of a study conducted by an international team of medical researchers under the direction of Professor V.
August 2015
2002 Treatment of Alzheimers Double Blind Study
Objective: To evaluate the effect of stabilized oral NADH (reduced nicotinamide adenine dinucleotide; ENADA®) on cognitive functioning in patients with AD.
Study by Dr Demarin on Alzheimers
Summary: This study was designed to evaluate the effect of stabilized oral reduced nicotinam,de adenine din ucleotide (NADH) on cognitive functioning in patients with Alzheimer’s dsease (AD).
ENADA Improvess the Cognitive Impairment of Alzheimers Patients
Although significant progress has been achieved in revealing the etiology of AD, the search for efficient therapy stays the man goal.
The Antioxidative Capacity of ENADA NADH in Humans
NADH is a strongly reducing agent and has been suggested to act – possibly by indirect means – as important antioxidant.
The Studies of Enada NADH Compiled for Your Review and Information.
Enada Co-E1 ( NADH) ( since 1993 ) is of vital importance to the world in general for good health support and it affects the body in a myriad of ways on a positive level.